1. Cavaleri, M., Sweeney, F., Gonzalez-Quevedo, R. & Carr, M. Shaping EU medicines regulation in the post COVID-19 era. Lancet Reg. Health Eur. 9, 100192 (2021).
2. ACT EU multi-annual Workplan 2022–2026 (Accelerating Clinical Trials in the EU, 2022); https://accelerating-clinical-trials.europa.eu/system/files/2023-04/act-eu-multi-annual-workplan-2022-2026_en.pdf
3. Accelerating Clinical Trials in the European Union (ACT EU). Concept paper: an EU multi-stakeholder platform for improving the EU clinical trials environment (Accelerating Clinical Trials in the EU, 2023); https://accelerating-clinical-trials.europa.eu/system/files/2023-10/ACT%20EU%20multi-stakeholder%20platform%20concept%20paper%20final%20update_1.pdf
4. COVID-19 Lessons learned. Joint report on the response to the Public Health Emergency (European Medicines Agency, 2023); https://www.ema.europa.eu/en/documents/report/covid-19-lessons-learned-joint-report-response-public-health-emergency_en.pdf
5. Report of the EMA/ETF workshop on Lessons Learned on Clinical Trials in Public Health Emergencies (European Medicines Agency, 2023); https://www.ema.europa.eu/en/documents/report/report-emaetf-workshop-lessons-learned-clinical-trials-public-health-emergencies_en.pdf